Quebec, Canada-based contract development and manufacturing organization has joined the Pharma & Biopharma Outsourcing Association.
Groupe PARIMA, a Quebec, Canada-based contract development and manufacturing organization (CDMO) specializing in non-sterile liquid, suspension, semi-solid, and spray drug products, has joined the Pharma & Biopharma Outsourcing Association (PBOA), a trade association for contract manufacturing and CDMOs, as a general member.
“With the rapid evolution of the pharmaceutical industry, the role of CDMOs has increased in prominence, working in ever-closer partnerships with our clients. Groupe PARIMA is enthusiastically joining PBOA to support the important efforts of the association and to contribute to the development of solutions to meet our collective challenges. We are convinced that this association of industry leaders will continue to work effectively with all stakeholders to find better ways to serve patients by helping to insure a reliable supply of high-quality and affordable medications,” said Louis-David Cantin, president of Groupe PARIMA, in a statement.
“I’ve known the team at Groupe PARIMA for a long time and I’m delighted to bring them into the PBOA. Our association’s mission is not only to represent our industry in the regulatory and legislative areas, but also to give CDMOs the opportunity to learn best practices from each other and to grow as a sector. Groupe PARIMA will be a valuable addition to the PBOA, including our Quality Technical Group,” said Gil Roth, President of the PBOA, in an Aug. 11, 2016 announcement.
Source: Pharma & Biopharma Outsourcing Association
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.